Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tandem Diabetes Care (TNDM) Inventory (2016 - 2025)

Tandem Diabetes Care's Inventory history spans 13 years, with the latest figure at $128.8 million for Q4 2025.

  • For Q4 2025, Inventory fell 13.93% year-over-year to $128.8 million; the TTM value through Dec 2025 reached $128.8 million, down 13.93%, while the annual FY2025 figure was $128.8 million, 13.93% down from the prior year.
  • Inventory reached $128.8 million in Q4 2025 per TNDM's latest filing, down from $137.3 million in the prior quarter.
  • In the past five years, Inventory ranged from a high of $161.7 million in Q2 2024 to a low of $65.7 million in Q3 2021.
  • Average Inventory over 5 years is $120.0 million, with a median of $134.4 million recorded in 2023.
  • Peak YoY movement for Inventory: surged 67.54% in 2023, then fell 13.93% in 2025.
  • A 5-year view of Inventory shows it stood at $68.6 million in 2021, then surged by 62.09% to $111.1 million in 2022, then surged by 42.14% to $157.9 million in 2023, then decreased by 5.27% to $149.6 million in 2024, then dropped by 13.93% to $128.8 million in 2025.
  • Per Business Quant, the three most recent readings for TNDM's Inventory are $128.8 million (Q4 2025), $137.3 million (Q3 2025), and $142.6 million (Q2 2025).